A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Asthma Drug Could Become Top Selling Product In Canada
Reply New Message
Prev Message Back To Forum Threaded View Next Message

AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Asthma Drug Could Become Top Selling Product In Canada

posted on Mar 22, 2022 02:43PM
Log in to use the IP Check tool [?]

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply